| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 09/05/2000 | US6114166 Human pluripotent hematopoietic colony stimulating factor and cell line producing same |
| 09/05/2000 | US6113951 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 09/05/2000 | US6113901 Immunopotentiating cd-3 antigen monoclonal antibodies |
| 09/05/2000 | CA2098183C Method for the purification of intact, correctly-folded insulin-like growth factor-1 |
| 09/05/2000 | CA2047685C Purified insulin mediators and purification process for same |
| 08/31/2000 | WO2000050456A2 Covalently bridged insulin dimers |
| 08/31/2000 | WO2000050446A1 Oligopeptide derivatives for the electrochemical measurement of protease activity |
| 08/31/2000 | WO2000050160A1 Negatively charged membrane |
| 08/31/2000 | WO2000049884A1 Purification of liquid protein hydrolysate and the resultant products |
| 08/31/2000 | WO2000043492A8 Method of site specific labeling of proteins and uses therefor |
| 08/31/2000 | WO2000018904A9 Secreted proteins and nucleic acids encoding them |
| 08/31/2000 | DE19908041A1 Kovalent verbrückte Insulindimere Covalently bridged insulin dimers |
| 08/31/2000 | CA2363827A1 Oligopeptide derivatives for the electrochemical measurement of protease activity |
| 08/30/2000 | EP1030867A1 Mammalian milk growth factor |
| 08/30/2000 | EP1030863A1 A method for attaching polyethylene glycol to macromolecules |
| 08/30/2000 | EP1030862A1 Viral clearance process |
| 08/30/2000 | EP1030831A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 08/30/2000 | EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 08/30/2000 | EP1030678A1 High throughput method for functionally classifying proteins identified using a genomics approach |
| 08/30/2000 | EP1030658A1 Method of building and maintaining bone |
| 08/30/2000 | EP0573605B1 Preparation of factor ix |
| 08/30/2000 | CN1265143A Prodn. of erythropoietin by endogenous gene activation |
| 08/30/2000 | CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn. |
| 08/30/2000 | CN1055932C Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing same |
| 08/30/2000 | CN1055931C Aglucone isoflavone enriched vegetable protein concentrate and process for prouducing same |
| 08/29/2000 | US6111069 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
| 08/29/2000 | US6111067 Bactericides against grampositive bacteria |
| 08/29/2000 | US6110688 Separating compounds from human urine; freezing human urine, thawing urine, separating precipitate by centrifuging, recovering precipitate, dissolvingin solution, dialysis, separating supernatant, isolate protein, detect with antibody |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | CA1341090C Vampire bat plasminogen activators |
| 08/24/2000 | WO2000049417A1 Methods for substrate-ligand interaction screening |
| 08/24/2000 | WO2000049173A2 Method and sample support system for separating and processing substances in situ |
| 08/24/2000 | WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 08/24/2000 | WO2000048703A1 Purification of biological substances |
| 08/24/2000 | WO2000013017A9 Method and device for producing and/or analyzing biochemical reaction supporting materials |
| 08/24/2000 | DE10006491A1 Selective enrichment or separation of biological material e.g. organisms, organs tissues, organelles, and membranes, in liquid media, comprises using stationary and mobile phases |
| 08/24/2000 | CA2645398A1 Universal plasma from antibodies-depleted blood |
| 08/24/2000 | CA2371880A1 Method and sample support system for separating and processing substances in situ |
| 08/24/2000 | CA2329016A1 Methods for substrate-ligand interaction screening |
| 08/23/2000 | EP1028976A2 Method for obtaining biologically active dimers of recombinant human growth factors from the cysteine knot family, use of dimers thus obtained |
| 08/23/2000 | EP1028747A1 Novel igf-i composition and its use |
| 08/23/2000 | EP1028742A1 Host derived proteins binding hcv: medical, diagnostic and purification use |
| 08/23/2000 | EP1028626A1 Method for the augmentation of gene expression |
| 08/23/2000 | EP0734397B1 Apparatus and method for polymer synthesis using arrays |
| 08/23/2000 | CN1263893A Renaturation equipment of modified protein |
| 08/23/2000 | CN1055702C Extraction of cell-bound protein from bordetella |
| 08/23/2000 | CN1055700C Therapeutic peptide derivatives |
| 08/22/2000 | US6107479 Introducing a nonremovable lipophilic capping group to an unreacted reactive group of oligomer which was not chain extended in previous step, then separating capped oligomer from elongated oligomer on a hydrophobic stationary phase |
| 08/22/2000 | US6107469 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody |
| 08/22/2000 | US6107458 Cyclic hexapeptides having antibiotic activity |
| 08/22/2000 | US6107283 Antitumor agents; diabetic therapy |
| 08/22/2000 | US6107104 Calcineurin deletion mutant which binds a-kinase anchor protein 79 and having defined amino acid sequence; for screening enzyme inhibitors for use as immunosuppressants with reduced side effects |
| 08/22/2000 | US6107059 Peptide library and screening method |
| 08/22/2000 | US6106842 Extraction of cell-bound protein from bordetella |
| 08/22/2000 | CA2176494C Purification of hemoglobin |
| 08/22/2000 | CA2056381C Cysteine thiol-protected peptides for use in immunoassays |
| 08/22/2000 | CA2018801C Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus |
| 08/17/2000 | WO2000047751A1 Intein-mediated protein ligation of expressed proteins |
| 08/17/2000 | WO2000047621A1 A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method |
| 08/17/2000 | WO2000047608A1 Process for the preparation of cyclic tetrapeptide derivatives |
| 08/17/2000 | WO2000047598A1 Method and apparatus for compound library preparation using optical modulator |
| 08/17/2000 | WO2000036398A8 Method and devices for detecting optical properties, especially luminescence reactions and refraction behaviour of molecules which are directly or indirectly bound on a support |
| 08/17/2000 | WO2000034317A3 Method for reducing immunogenicity of proteins |
| 08/17/2000 | WO2000018823A3 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 08/17/2000 | WO2000013026A9 Energy transfer dyes |
| 08/16/2000 | EP1028317A1 Method of inferring three-dimensional structure of protein |
| 08/16/2000 | EP1027454A1 Characterising polypeptides |
| 08/16/2000 | EP1027379A1 Method for producing polymeric solid phase supporting materials |
| 08/16/2000 | EP1027371A1 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma |
| 08/16/2000 | EP1027370A2 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules |
| 08/16/2000 | EP1027369A1 Methods of unfolding proteins using metal complexes |
| 08/16/2000 | EP1026988A1 Novel fluorescent reporter molecules and their applications including assays for caspases |
| 08/16/2000 | EP0755374B1 Process for peptide segment condensation |
| 08/16/2000 | CN1263534A A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
| 08/16/2000 | CN1263107A Ribosome deactivated protein-pumpkin protein |
| 08/16/2000 | CN1263106A Small molecule ribosome deactivated protein |
| 08/15/2000 | US6103889 Nucleic acid molecules encoding single-chain antigen-binding proteins |
| 08/15/2000 | US6103882 Producing a peptide ligand, amide or salt by subjecting fusion protein or peptide to cleavage of the peptide bond on the amino terminal side of a cysteine in the heterologous peptide |
| 08/15/2000 | US6103697 Novel homodimers that include cysteine-containing peptides having 4-15 amino acid residues |
| 08/15/2000 | US6103693 Method for isolation of highly pure von willebrand factor |
| 08/15/2000 | US6103502 Ultrafiltration process for desalination and concentration of a peptide in a cell-free fermentation medium |
| 08/15/2000 | CA2046601C Production and use of anthelmintic agents and protective immunogens |
| 08/15/2000 | CA1341083C Purified recombinant interleukin-2 and process for recovering and purifying same |
| 08/10/2000 | WO2000046365A1 Advanced antigen presentation platform |
| 08/10/2000 | WO2000046238A1 Volatilizable solid phase supports for compound synthesis |
| 08/10/2000 | WO2000045957A1 System, method and computer program product for automated fluid or gas delivery |
| 08/10/2000 | WO2000045950A1 Flow-through device and its use for binding polymers to membrane surfaces |
| 08/10/2000 | WO2000033084A3 Arrays of organic compounds attached to surfaces |
| 08/10/2000 | WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/10/2000 | WO2000010584A9 Method for detection of legionella bacteria employing purified antigen-specific antibodies |
| 08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
| 08/10/2000 | DE19904784A1 Durchflußeinrichtung sowie ihre Verwendung zum Binden von Polymeren an Membranoberflächen The flow-through and to their use for bonding of polymers to membrane surfaces |
| 08/10/2000 | DE19903125A1 Verfahren zur Trocknung von Proteinkristallen Process for drying protein crystals |
| 08/09/2000 | EP1026240A2 Generation and selection of recombinant varied binding proteins |
| 08/09/2000 | EP1026171A1 Polymer modification |
| 08/09/2000 | EP1025902A2 Apparatus and method for polymer synthesis using arrays |
| 08/09/2000 | EP1025853A2 Pharmaceutical composition containing S-nitroso-heme proteins and use thereof |
| 08/09/2000 | EP1025521A1 Computer method utilizing free energy calculations for ligand design and the prediction of binding targets |
| 08/09/2000 | EP1025437A1 A method for determining the affinity of proteins for chemical agents during screening of combinatorial libraries |
| 08/09/2000 | EP1025228A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |